CytoSorbents Corporation – Filings and Transcripts

NASDAQ: CTSO
Share price (3/13/26): $0.71
Market cap (3/13/26): $44.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Free writing prospectus

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration – amended

Registration of securities for employees

Ownership Filter

Chan Phillip P.

Mariani Peter J

Chan Phillip P.

Jones Edward Raymond

News Filter

Reports Third Quarter 2025 Financial Results and Provides Business Update

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Provides DrugSorb-ATR Regulatory Update

Updates U.S. FDA Regulatory Status of DrugSorb-ATR

Reports Second Quarter 2025 Financial Results and Provides Business Update

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission